Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Currier, Judith S."'
Autor:
Evering, Teresa H, Chew, Kara W, Giganti, Mark J, Moser, Carlee, Pinilla, Mauricio, Wohl, David Alain, Currier, Judith S, Eron, Joseph J, Javan, Arzhang Cyrus, Bender Ignacio, Rachel, Margolis, David, Zhu, Qing, Ma, Ji, Zhong, Lijie, Yan, Li, D'Andrea Nores, Ulises, Hoover, Keila, Mocherla, Bharat, Choudhary, Manish C, Deo, Rinki, Ritz, Justin, Fischer, William A, Fletcher, Courtney V, Li, Jonathan Z, Hughes, Michael D, Smith, Davey, Daar, Eric S, ACTIV-2/A5401 Study Team
Publikováno v:
Annals of internal medicine, vol 176, iss 5
BackgroundDevelopment of safe and effective SARS-CoV-2 therapeutics is a high priority. Amubarvimab and romlusevimab are noncompeting anti-SARS-CoV-2 monoclonal antibodies with an extended half-life.ObjectiveTo assess the safety and efficacy of amuba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::c79d1051380407ddaf9d917aa698652b
https://escholarship.org/uc/item/1pr201tq
https://escholarship.org/uc/item/1pr201tq
Autor:
Choudhary, Manish C, Chew, Kara W, Deo, Rinki, Flynn, James P, Regan, James, Crain, Charles R, Moser, Carlee, Hughes, Michael D, Ritz, Justin, Ribeiro, Ruy M, Ke, Ruian, Dragavon, Joan A, Javan, Arzhang Cyrus, Nirula, Ajay, Klekotka, Paul, Greninger, Alexander L, Fletcher, Courtney V, Daar, Eric S, Wohl, David A, Eron, Joseph J, Currier, Judith S, Parikh, Urvi M, Sieg, Scott F, Perelson, Alan S, Coombs, Robert W, Smith, Davey M, Li, Jonathan Z, ACTIV-2/A5401 Study Team
Publikováno v:
Nature microbiology, vol 7, iss 11
Nat Microbiol
Nat Microbiol
SARS-CoV-2 mutations that cause resistance to monoclonal antibody (mAb) therapy have been reported. However, it remains unclear whether in vivo emergence of SARS-CoV-2 resistance mutations alters viral replication dynamics or therapeutic efficacy in
Autor:
Williams, Paige L., Currier, Judith S., MacGregor, Rob Roy, Flexner, Charles, Chaisson, Richard
Publikováno v:
Clinical Infectious Diseases, 2003 Nov 01. 37(9), 1234-1243.
Externí odkaz:
https://www.jstor.org/stable/4483656
Autor:
Deo, Rinki, Choudhary, Manish C, Moser, Carlee, Ritz, Justin, Daar, Eric S, Wohl, David A, Greninger, Alexander L, Eron, Joseph J, Currier, Judith S, Hughes, Michael D, Smith, Davey M, Chew, Kara W, Li, Jonathan Z, ACTIV-2/A5401 Study Team
Publikováno v:
Annals of internal medicine, vol 176, iss 3
BackgroundAlthough symptom and viral rebound have been reported after nirmatrelvir-ritonavir treatment, the trajectories of symptoms and viral load during the natural course of COVID-19 have not been well described.ObjectiveTo characterize symptom an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::4167357fca39ad2e8e3471ebbfc1b246
https://escholarship.org/uc/item/2xj652jz
https://escholarship.org/uc/item/2xj652jz
Autor:
Ramirez, Sydney I, Grifoni, Alba, Weiskopf, Daniela, Parikh, Urvi M, Heaps, Amy, Faraji, Farhoud, Sieg, Scott F, Ritz, Justin, Moser, Carlee, Eron, Joseph J, Currier, Judith S, Klekotka, Paul, Sette, Alessandro, Wohl, David A, Daar, Eric S, Hughes, Michael D, Chew, Kara W, Smith, Davey M, Crotty, Shane, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team
Publikováno v:
JCI insight, vol 7, iss 24
Despite the widespread use of SARS-CoV-2-specific monoclonal antibody (mAb) therapy for the treatment of acute COVID-19, the impact of this therapy on the development of SARS-CoV-2-specific T cell responses has been unknown, resulting in uncertainty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::b28ef16a6d0cb44f490d4a1bad157888
https://escholarship.org/uc/item/2cj3m23p
https://escholarship.org/uc/item/2cj3m23p
Autor:
Bender Ignacio, Rachel A, Wohl, David A, Arends, Rosalin, Pilla Reddy, Venkatesh, Mu, Ying, Javan, Arzhang Cyrus, Hughes, Michael D, Eron, Joseph J, Currier, Judith S, Smith, Davey, Chew, Kara W, Gibbs, Michael, Fletcher, Courtney V
Publikováno v:
Clinical pharmacology and therapeutics, vol 112, iss 6
AZD7442 (Evusheld) is a combination of two human anti-severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs), tixagevimab (AZD8895) and cilgavimab (AZD1061). Route of administration is an important consideration to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::c4b75d262baeea78cfd16043769fd496
https://escholarship.org/uc/item/0x83039c
https://escholarship.org/uc/item/0x83039c
Autor:
Moser, Carlee, Li, Jonathan Z, Eron, Joseph J, Aga, Evgenia, Daar, Eric S, Wohl, David A, Coombs, Robert W, Javan, Arzhang Cyrus, Bender Ignacio, Rachel A, Jagannathan, Prasanna, Ritz, Justin, Sieg, Scott F, Parikh, Urvi M, Hughes, Michael D, Currier, Judith S, Smith, Davey M, Chew, Kara W, ACTIV-2/A5401 Study Team
Publikováno v:
Open forum infectious diseases, vol 9, iss 11
BackgroundIdentifying characteristics associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA shedding may be useful to understand viral compartmentalization, disease pathogenesis, and risks for viral transmission.MethodsPart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::e8be2edf1503432175a8dfa26234e054
https://escholarship.org/uc/item/1j29k6hg
https://escholarship.org/uc/item/1j29k6hg
Autor:
Phillips, Peter, Williams, Paige L., McCutchan, J. Allen, Cohn, Susan E., Lederman, Howard M., Currier, Judith S.
Publikováno v:
Clinical Infectious Diseases, 2005 May 01. 40(9), 1379-1381.
Externí odkaz:
https://www.jstor.org/stable/4484183
Autor:
Freeman, Michael L, Clagett, Brian M, Moisi, Daniela, Yeh, Eunice, Morris, Charles D, Ryu, Angela, Rodriguez, Benigno, Stein, James H, Deeks, Steven G, Currier, Judith S, Hsue, Priscilla Y, Anthony, Donald D, Calabrese, Leonard H, Ribaudo, Heather J, Lederman, Michael M
Publikováno v:
Frontiers in Immunology. 13
Inflammation associated with increased risk of comorbidities persists in people living with HIV (PWH) on combination antiretroviral therapy (ART). A recent placebo-controlled trial of low-dose methotrexate (MTX) in PWH found that numbers of total CD4
Autor:
Wilkin, Timothy J., Lalama, Christina M., McKinnon, John, Gandhi, Rajesh T., Lin, Nina, Landay, Alan, Ribaudo, Heather, Fox, Lawrence, Currier, Judith S., Mellors, John W., Gulick, Roy, Tenorio, Allan R.
Publikováno v:
The Journal of Infectious Diseases, 2012 Aug . 206(4), 534-542.
Externí odkaz:
http://dx.doi.org/10.1093/infdis/jis376